Clinical trials and foreign affairs: Key points to consider when conducting studies abroad
Cost effective clinical trials are being provided in various countries in Asia and Eastern Europe, the main reason for this is to increase the growth and revenue for this specialist industry, This has had an impact on many Pharmaceutical and Bio-tech companies who are now outsourcing the clinical trial research to these countries. The attraction of these emerging markets is acknowledged by many in the industry; where an expanding middle class allows for more healthcare spending and where there are a number of willing and treatment-naïve volunteers available to recruit.
The conduct of Clinical Trials has become cost effective in these countries.
Organisations such as pharmaceutical and biotechnology companies, as well as contract service providers, are faced with some challenging ethical business issues as sales and research continues to boom in these regions. Some countries are faced with corruption issues around clinical trials due to the need for logistical and institutional capacities, trials being approved are taken for granted or are increasingly difficult to attain which leads to back-handing or bribes for securing the necessary approval to conduct a specific clinical trial.
The Corruptions Perceptions Index, examined by Transparency International (a not-for-profit organisation based in Berlin), affords a foundation for which the hazzard of corruption can be estimated.The index is planned to rate countries based on the opinions of business execs and state analysts.India was ranked 85th , China 72nd and Brazil 18th out of 180 countries where the country ranked the lowest would be considered to be the least corrupt.
Pharmaceutical and Biotechnology organisations need to consider this before looking to outsource their studies in other countries. This industry should fully know the about the ethical violations that Clinical Research Organisations may come across If these organisations are ignorant towards this, the clinical trial may in turn be jeopardised or the trial outcome report could be made invalid if the CRO carrying out the study have breeched any ethics violations that may be in place. This could be detrimental for the organisation’s reputation, and could hinder any business in that country for the future.
Nicky Hargreaves has over 24 years in R&D, manufacturing, quality and regulatory affairs.”Trusted UK based Clinical Research organisations or clinical pharmacology companies who provide professional clinical trials UK (providing the statistical analysis, medical writing and the clinical research) that assists with the development of new drug entities are known to be the top resource.” Says Nicky; who is a microbiologist by training and has managed projects in numerous divisions, including pharmaceutical, medicinal, OTC, oral healthcare and animal healthcare.
* Before taking any medical advise you should consult your doctor. *
This entry was posted on Thursday, August 27th, 2009 at 4:31 am and is filed under General. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.